Elevance Health Inc.

NYSE: ELV · Real-Time Price · USD
316.48
4.48 (1.44%)
At close: Aug 20, 2025, 9:48 AM

Elevance Health Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
5.88B 5.91B 5.97B 6.38B 6.68B 6.23B 5.99B 6.12B 6.43B 6.21B 6B 6.17B 6.06B 6.22B 6.09B 5.52B 4.24B 4.72B
Depreciation & Amortization
1.46B 1.44B 1.39B 1.42B 1.52B 1.61B 1.75B 1.79B 1.82B 1.78B 1.68B 1.56B 1.46B 1.38B 1.3B 1.23B 1.19B 1.17B
Stock-Based Compensation
208M 210M 191M 292M 304M 290M 289M 290M 281M 275M 264M 250M 244M 241M 255M 265M 282M 280M
Other Working Capital
2.34B 971M -197M -6.7B -7.81B -6.94B -2.17B -798M 3.36B 3.37B 704M 4.98B 2.29B 2.96B 3.05B 4.36B 3.13B 4.34B
Other Non-Cash Items
-1.34B -1.03B -1.18B 591M 902M 1.22B 1.17B 1B 447M 409M 244M -432M -510M -1.01B -1.09B -482M -449M -94M
Deferred Income Tax
-434M -684M -374M -499M -243M -211M -602M -267M -297M -244M -81M -116M 4M 50M 173M -324M -608M -566M
Change in Working Capital
680M -984M -187M -6.06B -7.09B -5.58B -535M 573M 3.14B 3.9B 294M 4.16B 1.91B 1.52B 1.63B 4.29B 2.2B 5.18B
Operating Cash Flow
6.45B 4.85B 5.81B 2.13B 2.07B 3.57B 8.06B 9.51B 11.82B 12.33B 8.4B 11.59B 9.17B 8.4B 8.36B 10.51B 6.85B 10.68B
Capital Expenditures
-1.12B -1.17B -1.26B -1.26B -1.25B -1.27B -1.3B -1.27B -1.25B -1.2B -1.15B -1.19B -1.15B -1.14B -1.09B -1.02B -1.07B -1.02B
Cash Acquisitions
-3.67B -3.32B -4.45B -707M -626M -1.03B -1.55B -1.6B -1.69B -2.23B -649M -657M -643M -3.51B -3.48B -3.44B -3.51B -95M
Purchase of Investments
-16.05B -15.85B -17.99B -6.61B -8.62B -14.9B -16.24B -29.67B -29.34B -27.34B -24.95B -23.15B -20.7B -16.74B -18.67B -17.91B -19.58B -22.57B
Sales Maturities Of Investments
18.38B 17.71B 18.57B 4.27B 6.16B 12.95B 13.54B 27.96B 27.12B 24.37B 22.61B 19.89B 17.51B 13.22B 14.61B 15.28B 18.09B 18.38B
Other Investing Acitivies
-169M -125M -51M -253M -509M -441M -24M 320M 356M 224M -421M -707M -1.03B -742M -1.02B -1.27B -765M -1.54B
Investing Cash Flow
-2.62B -2.75B -5.17B -4.56B -4.84B -4.7B -5.57B -4.25B -4.81B -6.17B -4.56B -5.82B -6.01B -8.91B -9.64B -8.37B -6.84B -6.85B
Debt Repayment
2.84B 3.98B 5.56B 2.6B 2.67B 803M 739M 823M 637M 1.75B 1.79B 1.04B 1.01B 563M 3.04B 1.98B 1.82B 1.39B
Common Stock Repurchased
-3.13B -3.21B -2.9B -2.02B -2.44B -2.62B -2.68B -2.32B -2.42B -2.39B -2.32B -2.27B -2.14B -2B -1.9B -2.74B -3.04B -2.62B
Dividend Paid
-1.52B -1.51B -1.51B -1.48B -1.45B -1.42B -1.4B -1.35B -1.31B -1.27B -1.23B -1.2B -1.17B -1.14B -1.1B -1.06B -1.03B -991M
Other Financial Acitivies
90M 2M 39M 285M 526M 454M -17M -366M -384M -262M 432M 56M 349M -72M 392M 1.19B 1.47B 2.37B
Financial Cash Flow
-1.72B -748M 1.19B -609M -688M -2.79B -3.35B -3.21B -3.47B -2.17B -1.32B -2.38B -1.95B -2.64B 423M -629M -783M 142M
Net Cash Flow
2.06B 1.27B 1.76B -3.05B -3.49B -3.92B -861M 2.05B 3.54B 3.98B 2.51B 3.38B 1.2B -3.17B -861M 1.51B -770M 3.98B
Free Cash Flow
5.34B 3.67B 4.55B 871M 820M 2.3B 6.76B 8.25B 10.57B 11.13B 7.25B 10.39B 8.02B 7.26B 7.28B 9.48B 5.78B 9.66B